The New Generation of Antibody Therapeutics: Current Status and Future Prospects - OverviewCHI Insight Pharma Reports
June 1, 2012
More Antibody Technologies reports by CHI Insight Pharma Reports
Hematological Cancer Therapies by CHI Insight Pharma Reports
In recent years, newer and more specific therapies for hematological cancers have been developed, such as targeted small-molecule drugs and biological therapies including monoclonal antibodies. ...
Monoclonal Antibodies: A Segment of Major Growth by CHI Insight Pharma Reports
Monoclonal antibodies are highly valuable therapeutic agents and were among the best-selling drugs in the world in 2010. Global revenues from monoclonal antibody products will ...
Therapeutic Monoclonal Antibody Production by CHI Insight Pharma Reports
Bioprocessing is the branch of biotechnology dealing with the production and purification of biological materials of commercial interest. This report focuses on the wide ...
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment by CHI Insight Pharma ReportsSee all reports like this >>
In the nearly 35 years since the first process for creating mAbs was introduced, they have remained a centerpiece of the growing biotechnology industry. ...
We can help you find what you need. Call us or write us:
Need help in your search?
Antibody Technologies Reports
- Monoclonal Antibody Markets in China
- Analytical Tool - Antibodies and Peptides in Oncology
- Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017
- Ion Channel Modulators
- Antibody Technologies and Attrition Rates – an industry analysis 2013